Profil
Edmund Benami is associated with two companies, Bugatone Ltd.
and Neuralight, Inc. He is the founder of both companies.
At Neuralight, Inc., he holds the title of Chief Technology Officer since 2021, the year the company is founded.
Postes actifs de Edmund Benami
| Sociétés | Poste | Début |
|---|---|---|
Neuralight, Inc.
 Neuralight, Inc. Packaged SoftwareTechnology Services Neuralight, Inc. was founded in 2021 by Edmund Benami and Micha Y. Breakstone, with Micha Y. Breakstone serving as the CEO since then. The Israeli company is focused on transforming clinical development, diagnostics, and precision medicine in neurology with AI. The company is developing an AI-driven platform to accelerate and improve drug development and patient monitoring, as well as introduce precision care for patients with neurological disorders using oculometric data captured with a standard webcam or smartphone. | Fondateur | 01/02/2021 |
Anciens postes connus de Edmund Benami
| Sociétés | Poste | Fin |
|---|---|---|
Bugatone Ltd.
 Bugatone Ltd. Packaged SoftwareTechnology Services Bugatone Ltd. engages in the development of a software to improve audio quality and measure biographical data while listening to music or talking on the phone. The company was founded by Noam Petrank and Edmund Ben Ami on February 14, 2013 and is headquartered in Tel Aviv, Israel. | Fondateur | 01/06/2016 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Bugatone Ltd.
Bugatone Ltd. Packaged SoftwareTechnology Services Bugatone Ltd. engages in the development of a software to improve audio quality and measure biographical data while listening to music or talking on the phone. The company was founded by Noam Petrank and Edmund Ben Ami on February 14, 2013 and is headquartered in Tel Aviv, Israel. | Technology Services |
Neuralight, Inc.
Neuralight, Inc. Packaged SoftwareTechnology Services Neuralight, Inc. was founded in 2021 by Edmund Benami and Micha Y. Breakstone, with Micha Y. Breakstone serving as the CEO since then. The Israeli company is focused on transforming clinical development, diagnostics, and precision medicine in neurology with AI. The company is developing an AI-driven platform to accelerate and improve drug development and patient monitoring, as well as introduce precision care for patients with neurological disorders using oculometric data captured with a standard webcam or smartphone. | Technology Services |
